Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY - Get Free Report) is anticipated to post its quarterly earnings results on Wednesday, March 12th. Analysts expect Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München to post earnings of $0.17 per share and revenue of $18.71 billion for the quarter.
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY - Get Free Report) last issued its earnings results on Wednesday, February 26th. The financial services provider reported $0.16 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.17 by ($0.01). Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München had a return on equity of 18.94% and a net margin of 8.61%. The firm had revenue of $16.34 billion during the quarter, compared to analyst estimates of $19.10 billion. On average, analysts expect Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Price Performance
MURGY traded up $0.28 on Friday, reaching $12.28. The stock had a trading volume of 198,356 shares, compared to its average volume of 319,233. The firm has a 50-day moving average of $10.82 and a 200-day moving average of $10.63. Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München has a fifty-two week low of $8.44 and a fifty-two week high of $12.28. The company has a market capitalization of $82.13 billion, a price-to-earnings ratio of 7.98, a price-to-earnings-growth ratio of 1.72 and a beta of 0.98. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 0.20.
Analyst Ratings Changes
MURGY has been the topic of a number of analyst reports. Barclays upgraded Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München to a "strong-buy" rating in a research report on Tuesday, January 28th. UBS Group downgraded Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from a "strong-buy" rating to a "hold" rating in a research note on Thursday, December 19th.
Read Our Latest Report on MURGY
About Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München
(
Get Free Report)
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. It also offers life and health reinsurance solutions, such as digital underwriting and advanced analytics solutions, health insurance management system, financial market risks, financing, portfolio risk management, digitalized investment-linked solution, MIRA digital suite, MIRA POS, MIRApply insured and physician, claims risk adjustment, CLARA plus, data analytics, underwriting and claims, medical research, capital management, and health market.
See Also
Before you consider Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München wasn't on the list.
While Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
